TPA
LLY icon

Trivium Point Advisory’s Eli Lilly LLY Stock Holding History

Trivium Point Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Buy
13,340
+9,975
+296% +$10.2M 1.45% 11
2026
Q1 		$3.1M Sell
3,365
-432
-11% -$438K 0.56% 40
2025
Q4 		$4.08M Buy
3,797
+52
+1% +$49.7K 0.41% 64
2025
Q3 		$2.86M Buy
3,745
+779
+26% +$580K 0.29% 87
2025
Q2 		$2.31M Buy
2,966
+93
+3% +$72.3K 0.25% 105
2025
Q1 		$2.37M Buy
2,873
+278
+11% +$231K 0.29% 97
2024
Q4 		$2M Buy
2,595
+1,004
+63% +$831K 0.25% 110
2024
Q3 		$1.29M Buy
1,591
+1,129
+244% +$1.02M 0.18% 140
2024
Q2 		$418K Buy
+462
New +$370K 0.06% 223
2022
Q2 		– Sell
-2,196
Closed -$672K – 223
2022
Q1 		$672K Buy
2,196
+1,339
+156% +$345K 0.15% 150
2021
Q4 		$237K Buy
+857
New +$217K 0.05% 213

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trivium Point Advisory's LLY Position: Q2 2026 in Review

Trivium Point Advisory increased its Eli Lilly (LLY) stake by 296% in Q2 2026, buying an estimated $10.2M and bringing the position to 13,340 shares worth $16M. The position accounts for 1.45% of the portfolio, ranked #11.

Trivium Point Advisory first reported a position in LLY in Q4 2021 and has held it in 11 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Trivium Point Advisory held 13,340 shares of Eli Lilly worth $16M as of Q2 2026.
  • Trivium Point Advisory bought 9,975 Eli Lilly shares in Q2 2026, an estimated $10.2M.
  • Eli Lilly made up 1.45% of Trivium Point Advisory's portfolio in Q2 2026, its #11 holding.
  • Trivium Point Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 11 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trivium Point Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.